BiotechTube
Home/PulseSight Therapeutics/Francine Behar-Cohen, MD, PhD
FB

Francine Behar-Cohen, MD, PhD

Observer & Founder

PulseSight Therapeutics

Therapeutic Areas

OphthalmologyRetinal Diseases

PulseSight Therapeutics Pipeline

DrugIndicationPhase
PST-611Dry AMD / Geographic AtrophyPhase 1
PST-809Wet AMDPhase 1/2

Leadership Team at PulseSight Therapeutics

JG
Judith Greciet, PharmD
Chief Executive Officer
DS
Dirk Sauer
Independent Chair of the Board
View full PulseSight Therapeutics profile